News About: Pharm. Industry
New drugs developed in Korea aiming at U. S. markets.
Local pharmaceutical companies are trying to enter the U. S. markets with new drugs developed in Korea through appropriate clinical studies for the FDA approval.
Starting with Factive, developed by LG Life Science,...
Generic drugs' price-cut plan faces backlash
The government plans to improve financial soundness of the national health insurance by slashing the prices of generic drugs by 20 percent.
The move, however, has immediately triggered a strong backlash from the do...
U. S. NIH to finance Samjin viral new compound.
A new anti-viral agent developed by Samjin for the treatment of HIV, an AIDS virus, has been found of its excellent efficacy, and now Samjin may receive a financial support from the U. S. NIH for the development of an...
Boryung's Yonggaksan sales jump 50% in 2006
Borung Pharm said on November 22 its Yonggaksan sales in 2006 jumped more than 50 percent from the previous year, buoyed by robust domestic sales.
Yonggaksan is the most popular brand in the domestic antitussive & ...
Green Cross and OctoPlus signed joint development of new drug for mid-ear infection.
Green Cross signed an agreement with OctoPlus NV, a Netherlands company, on Nov. 22 for an exclusive distribution in Korea and joint development of OP-145, a drug for the treatment of chronic middle ear infection (oti...
FCB-Pharmicell to cerebrate GMP facility in Germany
FCB-Pharmicell, a local biopharmaceutical company, said it will complete the construction of its GMP facility in Germany on November 27, this year, to develop a new drug for the treatment of stroke using stem cells.
...
Listed drug companies to spend 70% of net incomes for R&D.
37 local drug companies are spending 5.47% of the sales or 71.31% of net incomes for their R&D.
The KPMA reported the 2005 business performances by 37 listed drug companies as 5,717,200 million won of the total sal...
Hanmi gets best IR awardHanmi Pharm was selected as this year's best IR (investor relations) drug company by the Korea Economic Daily (KED), a local economic daily, for the second consecutive year.
...
|
Dong-A to export U$45 million of prescription drugs to China.Dong-A achieved an oversea sale of Zydenar, an impotence drug, to the Middle East in the past, and now added an export sale of two more prescription drugs to China.
Dong-A si...
|
Toll manufacturing for health functional foods is available
Local GMP-endorsed health functional food firms will be able to produce other makers' items under a toll manufacturing contract, beginning November 13 this year, the Ministry of Health and Welfare said recently.
Ac...
